Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study

Geoffrey C. Kabat, Yikyung Park, Albert R. Hollenbeck, Arthur Schatzkin, Thomas E. Rohan

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Experimental evidence suggests that estrogen and other steroid hormones may protect against glioma. Although epidemiologic studies provide only weak support for a role of exogenous or endogenous hormones in gliogenesis, few cohort studies have addressed this question. The authors, therefore, examined the association between menstrual and reproductive factors, exogenous hormone use, and glioma risk among 225,355 women aged 50-71 years who completed the baseline questionnaire in the NIH-AARP Diet and Health Study. During 7.5 years of follow-up, 174 cases of incident, primary glioma were ascertained. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (95% CI) for exposures, taking potential confounders into account. Older age at menarche was positively associated with risk: HR 1.67 (95% CI: 1.03, 2.69). Other reproductive factors, including age at first live birth, parity, age at menopause, type of menopause (natural vs. medical) and exogenous hormone use showed no association with glioma risk. The results were similar when the analysis was restricted to cases with glioblastoma (N = 130). The present study provides only limited support for the hypothesis that menstrual/reproductive factors or exogenous hormone use play a role in gliogenesis.

Original languageEnglish (US)
Pages (from-to)944-950
Number of pages7
JournalInternational Journal of Cancer
Volume128
Issue number4
DOIs
StatePublished - Feb 15 2011

Fingerprint

Glioma
Hormones
Diet
Health
Menopause
Confidence Intervals
Menarche
Birth Order
Age Factors
Live Birth
Glioblastoma
Parity
Proportional Hazards Models
Epidemiologic Studies
Estrogens
Cohort Studies
Odds Ratio
Steroids

Keywords

  • glioma
  • hormones
  • menstrual factors
  • reproductive factors

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study. / Kabat, Geoffrey C.; Park, Yikyung; Hollenbeck, Albert R.; Schatzkin, Arthur; Rohan, Thomas E.

In: International Journal of Cancer, Vol. 128, No. 4, 15.02.2011, p. 944-950.

Research output: Contribution to journalArticle

Kabat, Geoffrey C. ; Park, Yikyung ; Hollenbeck, Albert R. ; Schatzkin, Arthur ; Rohan, Thomas E. / Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study. In: International Journal of Cancer. 2011 ; Vol. 128, No. 4. pp. 944-950.
@article{e358c42b7b9c41448e8dbca05d349176,
title = "Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study",
abstract = "Experimental evidence suggests that estrogen and other steroid hormones may protect against glioma. Although epidemiologic studies provide only weak support for a role of exogenous or endogenous hormones in gliogenesis, few cohort studies have addressed this question. The authors, therefore, examined the association between menstrual and reproductive factors, exogenous hormone use, and glioma risk among 225,355 women aged 50-71 years who completed the baseline questionnaire in the NIH-AARP Diet and Health Study. During 7.5 years of follow-up, 174 cases of incident, primary glioma were ascertained. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95{\%} confidence intervals (95{\%} CI) for exposures, taking potential confounders into account. Older age at menarche was positively associated with risk: HR 1.67 (95{\%} CI: 1.03, 2.69). Other reproductive factors, including age at first live birth, parity, age at menopause, type of menopause (natural vs. medical) and exogenous hormone use showed no association with glioma risk. The results were similar when the analysis was restricted to cases with glioblastoma (N = 130). The present study provides only limited support for the hypothesis that menstrual/reproductive factors or exogenous hormone use play a role in gliogenesis.",
keywords = "glioma, hormones, menstrual factors, reproductive factors",
author = "Kabat, {Geoffrey C.} and Yikyung Park and Hollenbeck, {Albert R.} and Arthur Schatzkin and Rohan, {Thomas E.}",
year = "2011",
month = "2",
day = "15",
doi = "10.1002/ijc.25413",
language = "English (US)",
volume = "128",
pages = "944--950",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study

AU - Kabat, Geoffrey C.

AU - Park, Yikyung

AU - Hollenbeck, Albert R.

AU - Schatzkin, Arthur

AU - Rohan, Thomas E.

PY - 2011/2/15

Y1 - 2011/2/15

N2 - Experimental evidence suggests that estrogen and other steroid hormones may protect against glioma. Although epidemiologic studies provide only weak support for a role of exogenous or endogenous hormones in gliogenesis, few cohort studies have addressed this question. The authors, therefore, examined the association between menstrual and reproductive factors, exogenous hormone use, and glioma risk among 225,355 women aged 50-71 years who completed the baseline questionnaire in the NIH-AARP Diet and Health Study. During 7.5 years of follow-up, 174 cases of incident, primary glioma were ascertained. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (95% CI) for exposures, taking potential confounders into account. Older age at menarche was positively associated with risk: HR 1.67 (95% CI: 1.03, 2.69). Other reproductive factors, including age at first live birth, parity, age at menopause, type of menopause (natural vs. medical) and exogenous hormone use showed no association with glioma risk. The results were similar when the analysis was restricted to cases with glioblastoma (N = 130). The present study provides only limited support for the hypothesis that menstrual/reproductive factors or exogenous hormone use play a role in gliogenesis.

AB - Experimental evidence suggests that estrogen and other steroid hormones may protect against glioma. Although epidemiologic studies provide only weak support for a role of exogenous or endogenous hormones in gliogenesis, few cohort studies have addressed this question. The authors, therefore, examined the association between menstrual and reproductive factors, exogenous hormone use, and glioma risk among 225,355 women aged 50-71 years who completed the baseline questionnaire in the NIH-AARP Diet and Health Study. During 7.5 years of follow-up, 174 cases of incident, primary glioma were ascertained. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (95% CI) for exposures, taking potential confounders into account. Older age at menarche was positively associated with risk: HR 1.67 (95% CI: 1.03, 2.69). Other reproductive factors, including age at first live birth, parity, age at menopause, type of menopause (natural vs. medical) and exogenous hormone use showed no association with glioma risk. The results were similar when the analysis was restricted to cases with glioblastoma (N = 130). The present study provides only limited support for the hypothesis that menstrual/reproductive factors or exogenous hormone use play a role in gliogenesis.

KW - glioma

KW - hormones

KW - menstrual factors

KW - reproductive factors

UR - http://www.scopus.com/inward/record.url?scp=78650594225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650594225&partnerID=8YFLogxK

U2 - 10.1002/ijc.25413

DO - 10.1002/ijc.25413

M3 - Article

VL - 128

SP - 944

EP - 950

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 4

ER -